semaglutide vs tirzepatide for diabetes versus Once Weekly in Patients with Type 2 Tirzepatide vs Semaglutide: Weight Loss,

It is a dual incretin receptor agonist that fundamentally changes how your body processes food, regulates blood sugar, and even responds to reward signals in your brain

However, the efficacy of the drug has yet to be confirmed by further studies

FREQUENTLY ASKED QUESTIONS Your Newport Center Urgent Care evaluation determines if semaglutide fits your specific health picture.

Its given as a once-weekly subcutaneous injection and follows this standard titration: Weeks 1 through 4: 2.5 mg Weeks 5 through 8: 5 mg Weeks 9 through 12: 7.5 mg (if moving toward higher doses) Weeks 13 through 16: 10 mg Weeks 17 through 20: 12.5 mg Week 20 onward: 15 mg (maximum dose) Not everyone will go to 15 mg